CPHI Milan 2026 concluded successfully on 8 October at Fiera Milano, Italy, after a three-day run. As a premier global pharmaceutical networking platform, the exhibition gathered pharmaceutical manufacturers, technology suppliers and industry professionals worldwide to explore industrial innovation and partnership opportunities.
Sino Bioengineering presented its one-stop bioprocessing solutions at the show. The team engaged in in-depth dialogues with clients and partners across Europe and global markets, sharing technical achievements and practical application experience in bioprocessing, while further expanding the scope and depth of international collaboration.
Beyond Product Showcase: Focused on Process Requirements
With continuous advances in biopharmaceutical technologies, global markets are raising persistent requirements for process efficiency, manufacturing flexibility, quality control and supply chain resilience. Optimizing production workflows and improving operational performance while assuring product quality has become a shared priority for biopharmaceutical enterprises.
Addressing these demands, Sino Bioengineering exhibited a diversified portfolio of products and solutions covering upstream and downstream bioprocessing workflows, including bioreactors, cell culture media, single-use bioprocess systems, filtration & purification units and fluid management products.
From early-stage R&D and process development, through pilot-scale-up to commercial manufacturing, Sino Bioengineering leverages its comprehensive product suite, expert technical support and adaptable solutions to help customers tackle process challenges at every development stage.
Face-to-Face Dialogues for Deeper Partnerships
During the exhibition, the Sino Bioengineering team held extensive discussions with industry clients and partners from multiple countries and regions. Technical conversations centered on real-world process requirements delivered greater value than conventional product presentations. Biopharma companies across varied markets and segments face distinct challenges in production scale, process routes, quality management and supply chain setup, placing increasingly diverse demands on bioprocess suppliers.
These interactions further validate Sino Bioengineering’s strategic direction to continuously refine its one-stop bioprocess platform: customers require not only high-performance equipment and consumables, but also a partner capable of understanding their process needs, collaboratively resolving practical issues and delivering consistent long-term support.
The exhibition enabled direct stakeholder communication and laid a solid foundation for subsequent technical exchanges and business cooperation.
Expanding Global Footprint & Building Long-Term Trust
Europe stands as a key hub for biopharmaceutical innovation and manufacturing, and represents a core focus market for Sino Bioengineering’s internationalization strategy. In recent years, as China’s biopharmaceutical supply chain matures, domestic bioprocess suppliers have stepped into broader global competition. International buyers now evaluate suppliers holistically, with growing emphasis on technical competence, quality management systems, delivery reliability and sustained service capabilities.
For Sino Bioengineering, participation in CPHI Milan serves not merely as a product and technology showcase, but also as a vital channel to gain insights into European market dynamics, align with international industry standards and expand its global partner network.
Through sustained R&D investment, product innovation and global business expansion, Sino Bioengineering aims to help more overseas customers recognize the advancements of China’s bioprocess supply chain. The company strives to build enduring trust via consistent product quality and professional services.
This journey calls for continuous commitment, with know-how accumulated through every product shipment, technical consultation and project execution. Sino Bioengineering will engage in global biopharma industry collaboration with an open and pragmatic mindset.
Exhibition Concludes, Partnerships Continue
The three-day Milan event delivered invaluable opportunities for Sino Bioengineering to connect with global industry peers, enabling the team to gain deeper insights into regional market needs and industry trends.
Moving forward, Sino Bioengineering will further enhance its one-stop bioprocess product and service ecosystem, strengthen collaboration with partners in Europe and worldwide, and continuously upgrade capabilities in product quality, technical support and supply chain services to deliver robust support for biopharma enterprises from R&D through commercial manufacturing.
CPHI Milan 2026 may have closed its doors, yet conversations initiated during the show remain ongoing. Sino Bioengineering looks forward to translating face-to-face discussions into tangible collaborations, advancing its capabilities while serving global customers, and contributing the professional expertise of a Chinese supplier to the biopharmaceutical industry.
See you next year in Frankfurt, Germany!
